miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia

Area of Science:

• Genetics and Molecular Biology
• Hematology
• Biochemistry

Background:

• Sickle cell anemia (SCA) is a genetic disorder caused by a mutation in the beta-globin gene, leading to abnormal hemoglobin production.
• Fetal hemoglobin (HbF) levels influence SCA's clinical presentation, and understanding its regulation is crucial for therapeutic development.

Purpose of the Study:

• To identify microRNA (miRNA) signatures associated with varying fetal hemoglobin (HbF) levels in sickle cell anemia (SCA) patients.
• To explore potential therapeutic targets by investigating miRNA regulation of γ-globin genes.

Main Methods:

• Next-generation sequencing was employed to identify pre-miRNA and mature miRNA expression profiles in SCA patients with different HbF levels.
• Bioinformatic tools (DIANA TOOL, miRWalk 2.0) were used to analyze miRNA involvement in relevant biological pathways.

Main Results:

• Specific miRNAs, including miR-184, miR-370-3p, and miR-451a, were found to be significantly upregulated, while miR-3609 and miR-483-5p were downregulated in SCA patients with high HbF.
• Identified miRNA targets are involved in critical pathways such as erythropoiesis, cell cycle regulation, and various signaling cascades (e.g., mTOR, PI3K-AKT).

Conclusions:

• Novel miRNA signatures associated with HbF regulation in SCA have been identified.
• These findings suggest that specific miRNAs and their target genes represent potential therapeutic avenues for modulating HbF production in sickle cell disease.